Natural bioactive compounds-doxorubicin combinations targeting topoisomerase II-alpha: Anticancer efficacy and safety
Ahmed Elfadadny, Rokaia F. Ragab, Rania Hamada, Soad K. Al Jaouni, Junjiang Fu, Shaker A. Mousa, Ali H. El‐Far
Topics & Concepts
TopoisomeraseCardiotoxicityDoxorubicinPharmacologyCancerTopoisomerase inhibitorDrugAdverse effectDrug discoveryMedicineBioinformaticsBiologyToxicityChemotherapyEnzymeInternal medicineBiochemistryCancer therapeutics and mechanismsChemotherapy-induced cardiotoxicity and mitigationBioactive Compounds and Antitumor Agents